---
nav_exclude: true
title: "Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422061"
source_layer: us_cdc_mmwr
category: scientific_report
date: 2021-05-20
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.

## 詳細內容

The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:13:56Z*
*資料來源: CDC MMWR*
